Compass Biotechnologies, Inc. Stock Other OTC
Equities
US20452Q1031
Pharmaceuticals
Financials (USD)
Sales 2018 | - | Sales 2019 | - | Capitalization | 158K |
---|---|---|---|---|---|
Net income 2018 | - | Net income 2019 | - | EV / Sales 2018 | - |
Net Debt 2018 | 516K | Net Debt 2019 | 480K | EV / Sales 2019 | - |
P/E ratio 2018 |
-2.59
x | P/E ratio 2019 |
-3.95
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 20-04-17 |
Mathew Knowles
SAM | Sales & Marketing | - | 19-07-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 20-04-17 |
1st Jan change | Capi. | |
---|---|---|
+37.15% | 6.01B | |
-16.04% | 4.47B | |
-11.16% | 3.11B | |
-1.40% | 3.01B | |
+0.12% | 2.6B | |
+38.69% | 1.85B | |
+1.11% | 1.66B | |
-10.34% | 1.63B | |
-12.97% | 1.53B |